TY - JOUR T1 - SITC 2018 workshop report: <em>Immuno-Oncology Biomarkers: State of the Art</em> JF - Journal for ImmunoTherapy of Cancer JO - J Immunother Cancer DO - 10.1186/s40425-018-0453-4 VL - 6 IS - 1 SP - 138 AU - Lisa H. Butterfield AU - Mary L. Disis AU - Bernard A. Fox AU - David R. Kaufman AU - Samir N. Khleif AU - Ena Wang AU - on behalf of the Society for Immunotherapy of Cancer Immuno-Oncology Biomarkers: State of the Art workshop speakers AU - Helen Chen AU - William D. Merritt AU - Sacha Gnjatic AU - Kara Davis AU - Ignacio Wistuba AU - James Lindsay AU - Stacey Adam AU - Fred Ramsdell AU - Kellie N. Smith AU - Davide Bedognetti AU - Chen Zhao AU - Evan Newell AU - Michael Angelo AU - David Furman AU - Marta Luksza AU - Pier Federico Gherardini AU - Priti Hegde AU - Martin Cheever AU - Steven Fling AU - Shawn Sweeney AU - Hongyue Dai AU - Catharine Young AU - John M. Kirkwood AU - Yana Najjar AU - Randy Sweis AU - Theresa LaVallee AU - Holden T. Maecker AU - Zoe Quandt Y1 - 2018/12/01 UR - http://jitc.bmj.com/content/6/1/138.abstract N2 - Identification of biomarkers in cancer immunotherapy that predict therapeutic response and/or limit adverse events are a critical need in the field. To address recent progress and hurdles around cancer biomarker development and utilization, the Society for Immunotherapy of Cancer (SITC) convened a workshop, “Immuno-Oncology Biomarkers: State of the Art,” on May 16–17, 2018. Topics discussed included challenges in handling biospecimens, identification and validation of new biomarkers, data sharing, and collaborating across disciplines to advance biomarker development. Panel discussions followed session presentations to help foster participant conversation and discuss future projects and collaborations. The results of the Workshop include the development of new initiatives for the SITC Biomarkers Committee. ER -